• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,808.48 544.15
( 0.71%)
Global Indices
Nasdaq
51,705.57 482.31
(0.94%)
Dow Jones
7,575.20 122.74
(1.65%)
Hang Seng
69,393.70 76.20
(0.11%)
Nikkei 225
10,435.69 -36.03
(-0.34%)
Forex
USD-INR
94.92 -0.57
(-0.60%)
EUR-INR
109.83 -0.42
(-0.38%)
GBP-INR
127.25 -0.49
(-0.38%)
JPY-INR
0.59 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
20.87
14518.15
EPS(TTM)
Face Value()
Div & Yield %
35.39
2
1.62
 

Baba Arts standalone net profit declines 77.27% in the March 2026 quarter
May 22,2026
Net profit of Baba Arts declined 77.27% to Rs 0.10 crore in the quarter ended March 2026 as against Rs 0.44 crore during the previous quarter ended March 2025. Sales rose 77.93% to Rs 5.16 crore in the quarter ended March 2026 as against Rs 2.90 crore during the previous quarter ended March 2025.

For the full year,net profit declined 54.86% to Rs 0.65 crore in the year ended March 2026 as against Rs 1.44 crore during the previous year ended March 2025. Sales rose 167.44% to Rs 14.95 crore in the year ended March 2026 as against Rs 5.59 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales5.162.90 78 14.955.59 167
OPM %-8.5311.03 --0.6012.70 -
PBDT0.120.62 -81 0.902.01 -55
PBT0.100.60 -83 0.841.95 -57
NP0.100.44 -77 0.651.44 -55